Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > DEA rescheduling is DONE!!! VP Kamala Harris...it's called
View:
Post by subaru1i on Mar 16, 2024 9:55pm

DEA rescheduling is DONE!!! VP Kamala Harris...it's called

STAGING!!!  Political 'staging' to be exact, a bit different than 'staging' your house when you put it up for sale.  No politicians with half a brain, especially the Vice President would stick her neck out on the line during an election year if Kamala Harris didn't already know it's going to happen.   Political staging...hope everyone enjoyed the show. 

(THANKS 1 HOT TECH WOMAN...YOU CRUSHED IT WITH THAT POST!!!)


That means, those on the wrong side of LABS in a big way, might have to stage their house because we are in the zone of HALT TRADE PENDING NEWS.
Comment by Starkicker on Mar 18, 2024 11:09am
Except WEED,, ACB and TLRY all up 10-20% and LABS is down 7. Not sure what it's going to take to move this thing in the right direction.
Comment by subaru1 on Mar 18, 2024 1:15pm
Subarue1i will come to you with an answer soon.
Comment by Olaf123 on Mar 18, 2024 1:32pm
Improving positive P/E's or meaningful contracts announcement. Won't move until then IMO. If you want to speculate, you have a lot of time to accumulate. For me, it is great.
Comment by Lvlchange on Mar 18, 2024 2:41pm
Just gotta make money and be profitable.  Nobody cares about anything else.
Comment by Lvlchange on Mar 18, 2024 2:45pm
"The Clock is Ticking on Cannabis", from 4 minutes agoby MT Newswires 4 minutes ago by MT Newswires Companies Mentioned: WEED, TLRY, ACB   02:39 PM EDT, 03/18/2024 (MT Newswires) -- With Q4 cannabis earnings wrapped up, Wedbush is "incrementally more positive" on the fundamental setup headed into 2024, as revenues, margins and cash flow ...more  
Comment by subaru1i on Mar 18, 2024 9:39pm
The legality of having a 'global pharmaceutical partner' can extend into a joint venture or complete buyout of Medipharm Labs and never involve improving positive P/E's or contract announcements.  
Comment by Olaf123 on Mar 18, 2024 11:02pm
I disagree with the joint venture. It does not mean anything, still speculation. A buyout would if they buy at ridiculous higher valuation only. We still have cash and slowing cash burn. It is the most unlikely thing in the short term because of the risks the buyer would take for that big price tag. They also hinted a plan to merge and acquire a company, if they get a very good deal it might help ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities